Related references
Note: Only part of the references are listed.Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years
Nazareno Suardi et al.
EUROPEAN UROLOGY (2015)
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
R. Leibowitz-Amit et al.
ANNALS OF ONCOLOGY (2014)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial
Thomas Wiegel et al.
EUROPEAN UROLOGY (2014)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Detection of Lymph Node Metastasis in Patients with Nodal Prostate Cancer Relapse Using 18F/11C-Choline Positron Emission Tomography/Computerized Tomography
Cordula A. Jilg et al.
JOURNAL OF UROLOGY (2014)
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
Cordula A. Jilg et al.
RADIATION ONCOLOGY (2014)
Moderately hypofractionated radiotherapy for localized prostate cancer Long-term outcome using IMRT and volumetric IGRT
M. Guckenberger et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy
Gunnar Lohm et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Biologically effective dose and definitive radiation treatment for localized prostate cancer
P. Sanpaolo et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer
Kilian Schiller et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Patterns and Predictors of Early Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiation Therapy in Men With pT3N0 Prostate Cancer: Implications for Multimodal Therapies
Alberto Briganti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
ROBOTIC IMAGE-GUIDED STEREOTACTIC RADIOTHERAPY, FOR ISOLATED RECURRENT PRIMARY, LYMPH NODE OR METASTATIC PROSTATE CANCER
Barbara Alicja Jereczek-Fossa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Radiotherapy after radical prostatectomy: immediate or early delayed?
D. Bottke et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
The Role of C-11-Choline-PET/CT-Guided Secondary Lymphadenectomy in Patients with PSA Failure after Radical Prostatectomy: Lessons Learned from Eight Cases
Thomas Martini et al.
ADVANCES IN UROLOGY (2012)
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
Maria Picchio et al.
EUROPEAN UROLOGY (2011)
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Patrizio Rigatti et al.
EUROPEAN UROLOGY (2011)
Intensity-modulated Radiotherapy Allows Escalation of the Radiation Dose to the Pelvic Lymph Nodes in Patients with Locally Advanced Prostate Cancer: Preliminary Results of a Phase I Dose Escalation Study
T. Guerrero Urbano et al.
CLINICAL ONCOLOGY (2010)
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy
Luigi F. Da Pozzo et al.
EUROPEAN UROLOGY (2009)
DOSE-VOLUME RELATIONSHIPS FOR ACUTE BOWEL TOXICITY IN PATIENTS TREATED WITH PELVIC NODAL IRRADIATION FOR PROSTATE CANCER
Claudio Fiorino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH-RISK PROSTATE CANCER
Colleen A. F. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
ADJUVANT AND SALVAGE RADIOTHERAPY AFTER PROSTATECTOMY FOR PROSTATE CANCER: A LITERATURE REVIEW
David Pasquier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer
Ludwig Rinnab et al.
BJU INTERNATIONAL (2007)
Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity
CS Higano
UROLOGY (2003)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han et al.
JOURNAL OF UROLOGY (2003)
Share Paper
